Biomarker of SLE. Increases DNMT1 expression and decreases CD70 and CD11a expression, and reverses the DNA hypomethylation of CD11a and CD70 in CD4+ T cells of SLE patients. The gene discussed is CD4; the disease is systemic lupus erythematosus.